U.S. markets close in 3 hours 22 minutes
  • S&P 500

    3,893.57
    -8.25 (-0.21%)
     
  • Dow 30

    31,557.06
    +21.55 (+0.07%)
     
  • Nasdaq

    13,485.31
    -103.51 (-0.76%)
     
  • Russell 2000

    2,245.72
    -29.60 (-1.30%)
     
  • Crude Oil

    60.94
    +0.30 (+0.49%)
     
  • Gold

    1,734.50
    +11.50 (+0.67%)
     
  • Silver

    26.80
    +0.12 (+0.44%)
     
  • EUR/USD

    1.2086
    +0.0026 (+0.22%)
     
  • 10-Yr Bond

    1.4120
    -0.0340 (-2.35%)
     
  • GBP/USD

    1.3967
    +0.0046 (+0.33%)
     
  • USD/JPY

    106.7370
    +0.0070 (+0.01%)
     
  • BTC-USD

    47,785.80
    -1,241.07 (-2.53%)
     
  • CMC Crypto 200

    959.21
    -27.44 (-2.78%)
     
  • FTSE 100

    6,613.75
    +25.22 (+0.38%)
     
  • Nikkei 225

    29,408.17
    -255.33 (-0.86%)
     

Health Canada okays GSK unit's monthly HIV injection

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

March 20 (Reuters) - GlaxoSmithKline's HIV treatments division said on Friday that Canada's healthcare regulator has approved its long-acting HIV injection, in a major win for the British drugmaker after a U.S. rejection late last year.

GSK's ViiV Healthcare said that Health Canada had given the green light to Cabenuva, a monthly injection to suppress the virus that causes AIDS and is aimed as an alternative to daily pills. (https://bit.ly/3aatmo8) (Reporting by Pushkala Aripaka in Bengaluru; Editing by Vinay Dwivedi)